Herbal medicinal product: Foeniculi amari fructus aetheroleumArray, F: Assessment finalised
Clinical Trials Information System (CTIS): Walk-in clinic - July 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 10 July 2024, 16:00 (CEST) to 10 July 2024, 17:00 (CEST)
CHMP PROM minutes for the meeting on 15 April 2024
Addendum to the Guideline on clinical development of vaccines to address clinical trials in immunocompromised individuals
Nitrosamines EMEA-H-A5(3)-1490 - Questions and answers for marketing authorisation holders / applicants on the CHMP Opinion for the Article 5(3) of Regulation (EC) No 726/2004 referral on nitrosamine impurities in human medicinal products
Human medicines European public assessment report (EPAR): Tenofovir disoproxil Mylan, tenofovir disoproxil, Date of authorisation: 08/12/2016, Revision: 19, Status: Authorised
Opinion/decision on a Paediatric investigation plan (PIP): Veltassa, Patiromer calcium, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Other, PIP number: P/0106/2023
Human medicines European public assessment report (EPAR): Vantavo (previously Alendronate sodium and colecalciferol, MSD), alendronic acid,colecalciferol, Date of authorisation: 16/10/2009, Revision: 20, Status: Authorised
Withdrawn application: Adcetris, 23/02/2024
Quarterly System Demo – Q2 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 26 June 2024, 09:00 (CEST) to 26 June 2024, 13:30 (CEST)